Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion type Assertion NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_head.
- NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion description "[Monoclonal antibodies targeting the external domain of EGFR have been shown to have clinical benefit in colorectal and head and neck cancer when combined with chemotherapy and/or radiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_provenance.
- NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion evidence source_evidence_literature NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_provenance.
- NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion SIO_000772 17290067 NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_provenance.
- NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion wasDerivedFrom befree-2016 NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_provenance.
- NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_assertion wasGeneratedBy ECO_0000203 NP593056.RABSdccGUHD-VCnLOX-UMdJl5d1lvaxLUPqmVENOiBFWs130_provenance.